SUMMIT THERAPEUTICS PLC's ticker is SMMT and the CUSIP is 86627R102. A total of 21 filers reported holding SUMMIT THERAPEUTICS PLC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $126,000 | -57.9% | 51,549 | +122.4% | 0.00% | – |
| Q1 2018 | $299,000 | -73.0% | 23,178 | -76.8% | 0.00% | -100.0% |
| Q4 2017 | $1,107,000 | +14.4% | 99,873 | +29.5% | 0.00% | +100.0% |
| Q3 2017 | $968,000 | +12.0% | 77,114 | +1.7% | 0.00% | -50.0% |
| Q2 2017 | $864,000 | -19.8% | 75,823 | -6.5% | 0.00% | 0.0% |
| Q1 2017 | $1,077,000 | +32.1% | 81,093 | -14.8% | 0.00% | 0.0% |
| Q4 2016 | $815,000 | – | 95,172 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Worth Asset Management, LLC | 10,956 | $20,488 | 0.02% |
| Lindbrook Capital, LLC | 782 | $1,462 | 0.00% |